NFA
KURA icon

Nationwide Fund Advisors’s Kura Oncology KURA Stock Holding History

Nationwide Fund Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-42,981
Closed -$643K – 1120
2017
Q3 		$643K Buy
42,981
+17,223
+67% +$162K ﹤0.01% 2048
2017
Q2 		$240K Buy
25,758
+10,258
+66% +$93.4K ﹤0.01% 2552
2017
Q1 		$136K Buy
+15,500
New +$114K ﹤0.01% 2740

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Nationwide Fund Advisors's KURA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Kura Oncology (KURA) in Q4 2017, closing a stake of 42,981 shares — an estimated $643K sold.

Nationwide Fund Advisors first reported a position in KURA in Q1 2017 and held it in 3 quarters. The position peaked at $643K in Q3 2017. 76 funds tracked by Wall St. Rank hold KURA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Kura Oncology position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 42,981 Kura Oncology shares in Q4 2017, an estimated $643K.
  • Nationwide Fund Advisors first reported a position in Kura Oncology in Q1 2017 and held it in 3 quarters.
  • Nationwide Fund Advisors's Kura Oncology position peaked at $643K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.